125 related articles for article (PubMed ID: 8185745)
1. Pharmacological characterization of a new milrinone analogue.
Dorigo P; Fraccarollo D; Santostasi G; Gaion RM; Maragno I; Floreani M; Carpenedo F; Jester M; Mosti L; Schenone P
Farmaco; 1994 Jan; 49(1):19-23. PubMed ID: 8185745
[TBL] [Abstract][Full Text] [Related]
2. An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria.
Dorigo P; Gaion RM; Belluco P; Mosti L; Borea PA; Maragno I
Br J Pharmacol; 1991 Dec; 104(4):867-72. PubMed ID: 1810600
[TBL] [Abstract][Full Text] [Related]
3. A new milrinone analog: role of binding to A1 adenosine receptor in its positive inotropic effect on isolated guinea pig and rat atria.
Floreani M; Borea PA; Gessi S; Mosti L; Fossa P; Dorigo P
J Pharmacol Exp Ther; 1997 Nov; 283(2):541-7. PubMed ID: 9353368
[TBL] [Abstract][Full Text] [Related]
4. New inotropic agents: milrinone analogs.
Dorigo P; Fraccarollo D; Gaion RM; Santostasi G; Borea PA; Floreani M; Mosti L; Maragno I
Gen Pharmacol; 1997 May; 28(5):781-8. PubMed ID: 9184820
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB
J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989
[TBL] [Abstract][Full Text] [Related]
7. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T
J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cardiotonic activity of 2-substituted 5-cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids and their methyl or ethyl esters.
Mosti L; Menozzi G; Schenone P; Dorigo P; Gaion RM; Belluco P
Farmaco; 1992 Apr; 47(4):427-37. PubMed ID: 1388591
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cardiotonic activity of novel pyrimidine derivatives: crystallographic and quantum chemical studies.
Dorigo P; Fraccarollo D; Santostasi G; Maragno I; Floreani M; Borea PA; Mosti L; Sansebastiano L; Fossa P; Orsini F; Benetollo F; Bombieri G
J Med Chem; 1996 Sep; 39(19):3671-83. PubMed ID: 8809156
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects of saterinone and milrinone in the isolated guinea pig myocardium.
Iven H; Brasch H; Armah BI
Arzneimittelforschung; 1988 Sep; 38(9):1298-302. PubMed ID: 2906246
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of the positive inotropic and alpha 1-adrenoceptor blocking agent saterinone.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Sep; 38(9):1287-92. PubMed ID: 2906245
[TBL] [Abstract][Full Text] [Related]
12. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.
Heber D; Heers C; Ravens U
Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456
[TBL] [Abstract][Full Text] [Related]
13. Reduction of 4-epiadriamycin cardiotoxicity by milrinone, a new cardiotonic agent.
Bossa R; Aresca P; Galatulas I; Ninci M
Anticancer Res; 1989; 9(3):605-8. PubMed ID: 2764506
[TBL] [Abstract][Full Text] [Related]
14. Inotropic agents. Synthesis and structure-activity relationships of new milrinone related cAMP PDE III inhibitors.
Fossa P; Boggia R; Lo Presti E; Mosti L; Dorigo P; Floreani M
Farmaco; 1997; 52(8-9):523-30. PubMed ID: 9507660
[TBL] [Abstract][Full Text] [Related]
15. Effects of the triazolopyrimidine trapidil on force of contraction, beating frequency and phosphodiesterase I--IV activity in guinea-pig hearts.
Bethke T; Mehl H; Meyer W; Schmitz W; Scholz H; Thomas K; Wenzlaff H
Arzneimittelforschung; 1991 May; 41(5):461-8. PubMed ID: 1716891
[TBL] [Abstract][Full Text] [Related]
16. Effect of milrinone on ethanol and halothane induced cardiodepression.
Neira S; Penna M
Acta Physiol Pharmacol Latinoam; 1988; 38(2):193-211. PubMed ID: 2847492
[TBL] [Abstract][Full Text] [Related]
17. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
[TBL] [Abstract][Full Text] [Related]
18. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.
Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M
Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101
[TBL] [Abstract][Full Text] [Related]
19. [Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives].
Hagen V; Hagen A; Krause EG; Klauschenz E
Pharmazie; 1992 Oct; 47(10):767-9. PubMed ID: 1480654
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone.
Fossa P; Menozzi G; Dorigo P; Floreani M; Mosti L
Bioorg Med Chem; 2003 Nov; 11(22):4749-59. PubMed ID: 14556790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
